Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial

NARecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

October 28, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Healthy Volunteer
Interventions
DIETARY_SUPPLEMENT

Urolithin A

Urolithin A (UA) is a widely available dietary supplement devoid of any known sided effects that is reported to improve mitochondrial function. The UA substance used in this investigation is regulated under Generally Recognized as Safe (GRAS) by the US FDA (GRN No. 000791) (https://www.fda.gov/media/120300/download) and is being advertised and sold as an oral supplement. The daily dose (1 gram) and duration (8 weeks) have already been tested in previous clinical trials.

DIETARY_SUPPLEMENT

Placebo

The placebo will consist of methylcellulose and will appear identical to the active supplement. The placebo will be provided by the manufacturer of Urolithin A.

Trial Locations (1)

21224

RECRUITING

National Institute of Aging, Clinical Research Unit, Baltimore

All Listed Sponsors
lead

National Institute on Aging (NIA)

NIH

NCT06274749 - Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial | Biotech Hunter | Biotech Hunter